{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:17:31Z","timestamp":1790011051592,"version":"4.0.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T00:00:00Z","timestamp":1390262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00018-014-1561-z","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T05:17:22Z","timestamp":1390195042000},"page":"2443-2450","source":"Crossref","is-referenced-by-count":15,"title":["Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens"],"prefix":"10.1007","volume":"71","author":[{"given":"Laure","family":"Guenin-Mac\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Chr\u00e9tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Demangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,21]]},"reference":[{"key":"1561_CR1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/dc11-0442","volume":"34","author":"FB Hu","year":"2011","unstructured":"Hu FB (2011) Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34:1249\u20131257","journal-title":"Diabetes Care"},{"key":"1561_CR2","first-page":"1352","volume":"51","author":"C Frank","year":"2005","unstructured":"Frank C, Bayoumi I, Westendorp C (2005) Approach to infected skin ulcers. Can Fam Physician 51:1352\u20131359","journal-title":"Can Fam Physician"},{"key":"1561_CR3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1024\/0301-1526\/a000230","volume":"41","author":"H Lawall","year":"2012","unstructured":"Lawall H (2012) Treatment of chronic wounds. Vasa 41:396\u2013409","journal-title":"Vasa"},{"key":"1561_CR4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047\u20131053","journal-title":"Diabetes Care"},{"key":"1561_CR5","first-page":"173","volume":"55","author":"FC Powell","year":"1985","unstructured":"Powell FC, Schroeter AL, Su WP, Perry HO (1985) Pyoderma gangrenosum: a review of 86 patients. Q J Med 55:173\u2013186","journal-title":"Q J Med"},{"key":"1561_CR6","first-page":"161","volume":"86","author":"JM Firnhaber","year":"2012","unstructured":"Firnhaber JM (2012) Diagnosis and treatment of basal cell and squamous cell carcinoma. Am Fam Physician 86:161\u2013168","journal-title":"Am Fam Physician"},{"key":"1561_CR7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/bjs.1800730905","volume":"73","author":"JV Cornwall","year":"1986","unstructured":"Cornwall JV, Dore CJ, Lewis JD (1986) Leg ulcers: epidemiology and aetiology. Br J Surg 73:693\u2013696","journal-title":"Br J Surg"},{"key":"1561_CR8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/10790268.2007.11753921","volume":"30","author":"R Salcido","year":"2007","unstructured":"Salcido R, Popescu A, Ahn C (2007) Animal models in pressure ulcer research. J Spinal Cord Med 30:107\u2013117","journal-title":"J Spinal Cord Med"},{"key":"1561_CR9","first-page":"969618","volume":"2011","author":"VW Wong","year":"2011","unstructured":"Wong VW, Sorkin M, Glotzbach JP, Longaker MT, Gurtner GC (2011) Surgical approaches to create murine models of human wound healing. J Biomed Biotechnol 2011:969618","journal-title":"J Biomed Biotechnol"},{"key":"1561_CR10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMra055289","volume":"355","author":"JJ Bergan","year":"2006","unstructured":"Bergan JJ et al (2006) Chronic venous disease. N Engl J Med 355:488\u2013498","journal-title":"N Engl J Med"},{"key":"1561_CR11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1524-475X.1996.40404.x","volume":"4","author":"BA Mast","year":"1996","unstructured":"Mast BA, Schultz GS (1996) Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 4:411\u2013420","journal-title":"Wound Repair Regen"},{"key":"1561_CR12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1524-475X.2003.11304.x","volume":"11","author":"TJ James","year":"2003","unstructured":"James TJ, Hughes MA, Cherry GW, Taylor RP (2003) Evidence of oxidative stress in chronic venous ulcers. Wound Repair Regen 11:172\u2013176","journal-title":"Wound Repair Regen"},{"key":"1561_CR13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1067-1927.2004.12406.x","volume":"12","author":"R Moseley","year":"2004","unstructured":"Moseley R et al (2004) Comparison of oxidative stress biomarker profiles between acute and chronic wound environments. Wound Repair Regen 12:419\u2013429","journal-title":"Wound Repair Regen"},{"key":"1561_CR14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1046\/j.1523-1747.2001.01345.x","volume":"116","author":"J Wenk","year":"2001","unstructured":"Wenk J et al (2001) Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. J Invest Dermatol 116:833\u2013839","journal-title":"J Invest Dermatol"},{"key":"1561_CR15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.0022-202X.2005.23789.x","volume":"125","author":"SJ Dalton","year":"2005","unstructured":"Dalton SJ, Mitchell DC, Whiting CV, Tarlton JF (2005) Abnormal extracellular matrix metabolism in chronically ischemic skin: a mechanism for dermal failure in leg ulcers. J Invest Dermatol 125:373\u2013379","journal-title":"J Invest Dermatol"},{"key":"1561_CR16","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.jid.5700651","volume":"127","author":"SJ Dalton","year":"2007","unstructured":"Dalton SJ, Whiting CV, Bailey JR, Mitchell DC, Tarlton JF (2007) Mechanisms of chronic skin ulceration linking lactate, transforming growth factor-beta, vascular endothelial growth factor, collagen remodeling, collagen stability, and defective angiogenesis. J Invest Dermatol 127:958\u2013968","journal-title":"J Invest Dermatol"},{"key":"1561_CR17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jcp.10065","volume":"191","author":"V Falanga","year":"2002","unstructured":"Falanga V, Zhou L, Yufit T (2002) Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF-beta1. J Cell Physiol 191:42\u201350","journal-title":"J Cell Physiol"},{"key":"1561_CR18","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1016\/S0021-9258(18)98977-5","volume":"266","author":"T Salo","year":"1991","unstructured":"Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H (1991) Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 266:11436\u201311441","journal-title":"J Biol Chem"},{"key":"1561_CR19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/1523-1747.ep12286453","volume":"108","author":"M Detmar","year":"1997","unstructured":"Detmar M et al (1997) Hypoxia regulates the expression of vascular permeability factor\/vascular endothelial growth factor (VPF\/VEGF) and its receptors in human skin. J Invest Dermatol 108:263\u2013268","journal-title":"J Invest Dermatol"},{"key":"1561_CR20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2249.1999.00775.x","volume":"115","author":"B Berse","year":"1999","unstructured":"Berse B et al (1999) Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 115:176\u2013182","journal-title":"Clin Exp Immunol"},{"key":"1561_CR21","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1371\/journal.pmed.0020108","volume":"2","author":"PD Johnson","year":"2005","unstructured":"Johnson PD et al (2005) Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control. PLoS Med 2:e108","journal-title":"PLoS Med"},{"key":"1561_CR22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1473-3099(09)70234-8","volume":"9","author":"MT Silva","year":"2009","unstructured":"Silva MT, Portaels F, Pedrosa J (2009) Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer. Lancet Infect Dis 9:699\u2013710","journal-title":"Lancet Infect Dis"},{"key":"1561_CR23","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0140-6736(03)14417-0","volume":"362","author":"TS Werf van der","year":"2003","unstructured":"van der Werf TS, Stinear T, Stienstra Y, van der Graaf WT, Small PL (2003) Mycolactones and Mycobacterium ulcerans disease. Lancet 362:1062\u20131064","journal-title":"Lancet"},{"key":"1561_CR24","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(06)68807-7","volume":"367","author":"M Wansbrough-Jones","year":"2006","unstructured":"Wansbrough-Jones M, Phillips R (2006) Buruli ulcer: emerging from obscurity. Lancet 367:1849\u20131858","journal-title":"Lancet"},{"key":"1561_CR25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3201\/eid0802.010119","volume":"8","author":"G Amofah","year":"2002","unstructured":"Amofah G et al (2002) Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis 8:167\u2013170","journal-title":"Emerg Infect Dis"},{"key":"1561_CR26","first-page":"4","volume":"11","author":"SJ Khan","year":"2005","unstructured":"Khan SJ, Muneeb S (2005) Cutaneous leishmaniasis in Pakistan. Dermatol Online J 11:4","journal-title":"Dermatol Online J"},{"key":"1561_CR27","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1128\/AEM.63.10.4135-4138.1997","volume":"63","author":"BC Ross","year":"1997","unstructured":"Ross BC et al (1997) Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease. Appl Environ Microbiol 63:4135\u20134138","journal-title":"Appl Environ Microbiol"},{"key":"1561_CR28","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1086\/367660","volume":"36","author":"M Debacker","year":"2003","unstructured":"Debacker M, Zinsou C, Aguiar J, Meyers WM, Portaels F (2003) First case of Mycobacterium ulcerans disease (Buruli ulcer) following a human bite. Clin Infect Dis 36:e67\u2013e68","journal-title":"Clin Infect Dis"},{"key":"1561_CR29","doi-asserted-by":"crossref","first-page":"e911","DOI":"10.1371\/journal.pntd.0000911","volume":"4","author":"RW Merritt","year":"2010","unstructured":"Merritt RW et al (2010) Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl Trop Dis 4:e911","journal-title":"PLoS Negl Trop Dis"},{"key":"1561_CR30","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3201\/eid0906.020485","volume":"9","author":"J Guarner","year":"2003","unstructured":"Guarner J et al (2003) Histopathologic features of Mycobacterium ulcerans infection. Emerg Infect Dis 9:651\u2013656","journal-title":"Emerg Infect Dis"},{"key":"1561_CR31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0140-6736(91)90791-M","volume":"337","author":"J Hayman","year":"1991","unstructured":"Hayman J (1991) Mycobacterium ulcerans infection. Lancet 337:124","journal-title":"Lancet"},{"key":"1561_CR32","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3109\/00313028509084759","volume":"17","author":"J Hayman","year":"1985","unstructured":"Hayman J, McQueen A (1985) The pathology of Mycobacterium ulcerans infection. Pathology 17:594\u2013600","journal-title":"Pathology"},{"key":"1561_CR33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1189\/jlb.1005581","volume":"79","author":"D Yeboah-Manu","year":"2006","unstructured":"Yeboah-Manu D et al (2006) Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans. J Leukoc Biol 79:1150\u20131156","journal-title":"J Leukoc Biol"},{"key":"1561_CR34","doi-asserted-by":"crossref","unstructured":"Phillips, R., et al (2009) Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with Buruli ulcer disease. J Infect Dis 200:1675\u20131684","DOI":"10.1086\/646615"},{"key":"1561_CR35","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.283.5403.854","volume":"283","author":"KM George","year":"1999","unstructured":"George KM et al (1999) Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283:854\u2013857","journal-title":"Science"},{"key":"1561_CR36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1039\/b803101k","volume":"25","author":"H Hong","year":"2008","unstructured":"Hong H, Demangel C, Pidot SJ, Leadlay PF, Stinear T (2008) Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria. Nat Prod Rep 25:447\u2013454","journal-title":"Nat Prod Rep"},{"key":"1561_CR37","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.20070234","volume":"204","author":"E Coutanceau","year":"2007","unstructured":"Coutanceau E et al (2007) Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone. J Exp Med 204:1395\u20131403","journal-title":"J Exp Med"},{"key":"1561_CR38","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1462-5822.2005.00546.x","volume":"7","author":"E Coutanceau","year":"2005","unstructured":"Coutanceau E et al (2005) Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin. Cell Microbiol 7:1187\u20131196","journal-title":"Cell Microbiol"},{"key":"1561_CR39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrmicro2077","volume":"7","author":"C Demangel","year":"2009","unstructured":"Demangel C, Stinear TP, Cole ST (2009) Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans. Nat Rev Microbiol 7:50\u201360","journal-title":"Nat Rev Microbiol"},{"key":"1561_CR40","doi-asserted-by":"crossref","first-page":"12833","DOI":"10.1073\/pnas.1016496108","volume":"108","author":"L Guenin-Mace","year":"2011","unstructured":"Guenin-Mace L et al (2011) Mycolactone impairs T cell homing by suppressing microRNA control of l-selectin expression. Proc Natl Acad Sci USA 108:12833\u201312838","journal-title":"Proc Natl Acad Sci USA"},{"key":"1561_CR41","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.4049\/jimmunol.163.7.3928","volume":"163","author":"AA Pahlevan","year":"1999","unstructured":"Pahlevan AA et al (1999) The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte\/T cell cytokine production and NF-kappa B function. J Immunol 163:3928\u20133935","journal-title":"J Immunol"},{"key":"1561_CR42","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.4049\/jimmunol.0802294","volume":"182","author":"RE Simmonds","year":"2009","unstructured":"Simmonds RE, Lali FV, Smallie T, Small PL, Foxwell BM (2009) Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism. J Immunol 182:2194\u20132202","journal-title":"J Immunol"},{"key":"1561_CR43","doi-asserted-by":"crossref","first-page":"e1252","DOI":"10.1371\/journal.pntd.0001252","volume":"5","author":"MT Ruf","year":"2011","unstructured":"Ruf MT et al (2011) Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection? PLoS Negl Trop Dis 5:e1252","journal-title":"PLoS Negl Trop Dis"},{"key":"1561_CR44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/AAC.05543-11","volume":"56","author":"MT Ruf","year":"2012","unstructured":"Ruf MT et al (2012) Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model. Antimicrob Agents Chemother 56:687\u2013696","journal-title":"Antimicrob Agents Chemother"},{"key":"1561_CR45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1517\/14712590802631854","volume":"9","author":"D Schutte","year":"2009","unstructured":"Schutte D, Pluschke G (2009) Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer). Expert Opin Biol Ther 9:187\u2013200","journal-title":"Expert Opin Biol Ther"},{"key":"1561_CR46","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.pntd.0000002","volume":"1","author":"D Schutte","year":"2007","unstructured":"Schutte D et al (2007) Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin. PLoS Negl Trop Dis 1:e2","journal-title":"PLoS Negl Trop Dis"},{"key":"1561_CR47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2133.2008.08879.x","volume":"160","author":"D Schutte","year":"2009","unstructured":"Schutte D, Umboock A, Pluschke G (2009) Phagocytosis of Mycobacterium ulcerans in the course of rifampicin and streptomycin chemotherapy in Buruli ulcer lesions. Br J Dermatol 160:273\u2013283","journal-title":"Br J Dermatol"},{"key":"1561_CR48","doi-asserted-by":"crossref","unstructured":"Guenin-Mace L et al (2013) Mycolactone activation of Wiskott\u2013Aldrich syndrome proteins underpins Buruli ulcer formation. J Clin Invest 123:1501\u20131512","DOI":"10.1172\/JCI66576"},{"key":"1561_CR49","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ncb1001-897","volume":"3","author":"SB Snapper","year":"2001","unstructured":"Snapper SB et al (2001) N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility. Nat Cell Biol 3:897\u2013904","journal-title":"Nat Cell Biol"},{"key":"1561_CR50","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1073\/pnas.96.7.3739","volume":"96","author":"LM Machesky","year":"1999","unstructured":"Machesky LM et al (1999) Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2\/3 complex. Proc Natl Acad Sci USA 96:3739\u20133744","journal-title":"Proc Natl Acad Sci USA"},{"key":"1561_CR51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0092-8674(00)80732-1","volume":"97","author":"R Rohatgi","year":"1999","unstructured":"Rohatgi R et al (1999) The interaction between N-WASP and the Arp2\/3 complex links Cdc42-dependent signals to actin assembly. Cell 97:221\u2013231","journal-title":"Cell"},{"key":"1561_CR52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nri2724","volume":"10","author":"AJ Thrasher","year":"2010","unstructured":"Thrasher AJ, Burns SO (2010) WASP: a key immunological multitasker. Nat Rev Immunol 10:182\u2013192","journal-title":"Nat Rev Immunol"},{"key":"1561_CR53","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ncb2290","volume":"13","author":"EM Kovacs","year":"2011","unstructured":"Kovacs EM et al (2011) N-WASP regulates the epithelial junctional actin cytoskeleton through a non-canonical post-nucleation pathway. Nat Cell Biol 13:934\u2013943","journal-title":"Nat Cell Biol"},{"key":"1561_CR54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1242\/jcs.053835","volume":"123","author":"T Lefever","year":"2010","unstructured":"Lefever T et al (2010) N-WASP is a novel regulator of hair-follicle cycling that controls antiproliferative TGF{beta} pathways. J Cell Sci 123:128\u2013140","journal-title":"J Cell Sci"},{"key":"1561_CR55","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1172\/JCI36478","volume":"120","author":"A Lyubimova","year":"2010","unstructured":"Lyubimova A et al (2010) Neural Wiskott\u2013Aldrich syndrome protein modulates Wnt signaling and is required for hair follicle cycling in mice. J Clin Invest 120:446\u2013456","journal-title":"J Clin Invest"},{"key":"1561_CR56","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1038\/onc.2008.347","volume":"27","author":"S Etienne-Manneville","year":"2008","unstructured":"Etienne-Manneville S (2008) Polarity proteins in migration and invasion. Oncogene 27:6970\u20136980","journal-title":"Oncogene"},{"key":"1561_CR57","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nsmb796","volume":"11","author":"JR Peterson","year":"2004","unstructured":"Peterson JR et al (2004) Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation. Nat Struct Mol Biol 11:747\u2013755","journal-title":"Nat Struct Mol Biol"},{"key":"1561_CR58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/path.1711410109","volume":"141","author":"DS Ridley","year":"1983","unstructured":"Ridley DS, Ridley MJ (1983) The evolution of the lesion in cutaneous leishmaniasis. J Pathol 141:83\u201396","journal-title":"J Pathol"},{"key":"1561_CR59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0190-9622(96)80121-6","volume":"34","author":"SA Grevelink","year":"1996","unstructured":"Grevelink SA, Lerner EA (1996) Leishmaniasis. J Am Acad Dermatol 34:257\u2013272","journal-title":"J Am Acad Dermatol"},{"key":"1561_CR60","first-page":"412","volume":"47","author":"U Sharma","year":"2009","unstructured":"Sharma U, Singh S (2009) Immunobiology of leishmaniasis. Indian J Exp Biol 47:412\u2013423","journal-title":"Indian J Exp Biol"},{"key":"1561_CR61","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000246316","volume":"192","author":"G Kolde","year":"1996","unstructured":"Kolde G, Luger T, Sorg C, Sunderkotter C (1996) Successful treatment of cutaneous leishmaniasis using systemic interferon-gamma. Dermatology 192:56\u201360","journal-title":"Dermatology"},{"key":"1561_CR62","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-0560.2011.01844.x","volume":"39","author":"J Saab","year":"2012","unstructured":"Saab J et al (2012) Cutaneous leishmaniasis mimicking inflammatory and neoplastic processes: a clinical, histopathological and molecular study of 57 cases. J Cutan Pathol 39:251\u2013262","journal-title":"J Cutan Pathol"},{"key":"1561_CR63","doi-asserted-by":"crossref","first-page":"e844","DOI":"10.1371\/journal.pntd.0000844","volume":"4","author":"G Tasew","year":"2010","unstructured":"Tasew G et al (2010) Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration. PLoS Negl Trop Dis 4:e844","journal-title":"PLoS Negl Trop Dis"},{"key":"1561_CR64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fimmu.2012.00163","volume":"3","author":"B Rethi","year":"2012","unstructured":"Rethi B, Eidsmo L (2012) FasL and TRAIL signaling in the skin during cutaneous leishmaniasis\u2014implications for tissue immunopathology and infectious control. Front Immunol 3:163","journal-title":"Front Immunol"},{"key":"1561_CR65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4269\/ajtmh.2011.10-0680","volume":"85","author":"F Oliveira","year":"2011","unstructured":"Oliveira F et al (2011) Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis. Am J Trop Med Hyg 85:70\u201373","journal-title":"Am J Trop Med Hyg"},{"key":"1561_CR66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0882-4010(02)00210-3","volume":"34","author":"DS Snyder","year":"2003","unstructured":"Snyder DS, Small PL (2003) Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans. Microb Pathog 34:91\u2013101","journal-title":"Microb Pathog"},{"key":"1561_CR67","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/IAI.68.2.877-883.2000","volume":"68","author":"KM George","year":"2000","unstructured":"George KM, Pascopella L, Welty DM, Small PL (2000) A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immun 68:877\u2013883","journal-title":"Infect Immun"},{"key":"1561_CR68","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1586\/14760584.2.4.561","volume":"2","author":"K Huygen","year":"2003","unstructured":"Huygen K (2003) Prospects for vaccine development against Buruli disease. Expert Rev Vaccines 2:561\u2013569","journal-title":"Expert Rev Vaccines"},{"key":"1561_CR69","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1128\/AAC.00730-07","volume":"51","author":"BH Ji","year":"2007","unstructured":"Ji BH, Chauffour A, Robert J, Lefrancois S, Jarlier V (2007) Orally administered combined regimens for treatment of Mycobacterium ulcerans infection in mice. Antimicrob Agents Ch 51:3737\u20133739","journal-title":"Antimicrob Agents Ch"},{"key":"1561_CR70","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1074\/jbc.M112.440396","volume":"288","author":"C Rajput","year":"2013","unstructured":"Rajput C et al (2013) Neural Wiskott\u2013Aldrich syndrome protein (N-WASP)-mediated p120-catenin interaction with Arp2-Actin complex stabilizes endothelial adherens junctions. J Biol Chem 288:4241\u20134250","journal-title":"J Biol Chem"},{"key":"1561_CR71","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/cir856","volume":"54","author":"WA Nienhuis","year":"2012","unstructured":"Nienhuis WA et al (2012) Paradoxical responses after start of antimicrobial treatment in Mycobacterium ulcerans infection. Clin Infect Dis 54:519\u2013526","journal-title":"Clin Infect Dis"},{"key":"1561_CR72","doi-asserted-by":"crossref","first-page":"e1767","DOI":"10.1371\/journal.pntd.0001767","volume":"6","author":"ND Friedman","year":"2012","unstructured":"Friedman ND, McDonald AH, Robson ME, O\u2019Brien DP (2012) Corticosteroid use for paradoxical reactions during antibiotic treatment for Mycobacterium ulcerans. PLoS Negl Trop Dis 6:e1767","journal-title":"PLoS Negl Trop Dis"},{"key":"1561_CR73","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5694\/mja12.11559","volume":"198","author":"JM Trevillyan","year":"2013","unstructured":"Trevillyan JM, Johnson PD (2013) Steroids control paradoxical worsening of Mycobacterium ulcerans infection following initiation of antibiotic therapy. Med J Aust 198:443\u2013444","journal-title":"Med J Aust"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-014-1561-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-014-1561-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-014-1561-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T22:43:53Z","timestamp":1688942633000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-014-1561-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,21]]},"references-count":73,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1561"],"URL":"https:\/\/doi.org\/10.1007\/s00018-014-1561-z","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,21]]}}}